HYDREIGHT TECHNOLOGIES INC (NURS.CA) Forecast, Price Target & Analyst Ratings

TSX-V:NURSCA44877L1013

Current stock price

3.69 CAD
+0.27 (+7.89%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HYDREIGHT TECHNOLOGIES INC (NURS.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$9.95
+ 169.51% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 5, 2026
Period
Q4 / 2025
EPS Estimate
CA$0.02
Revenue Estimate
15.085M

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$9.95
Upside
+ 169.51%
From current price of CA$3.69 to mean target of CA$9.95, Based on 6 analyst forecasts
Low
CA$9.60
Median
CA$9.95
High
CA$10.50

Price Target Revisions

1 Month
0.00%
3 Months
27.17%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for NURS.CA. The average price target is 9.95 CAD. This implies a price increase of 169.51% is expected in the next year compared to the current price of 3.69.
The average price target has been revised upward by 27.17% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

NURS Current Analyst RatingNURS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

NURS Historical Analyst RatingsNURS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
NURS.CA was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about NURS.CA.
In the previous month the buy percentage consensus was at a similar level.
NURS.CA was analyzed by 6 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-27Beacon SecuritiesMaintains Buy -> Buy
2025-09-15Maxim GroupMaintains Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 5, 2026
Period
Q4 / 2025
EPS Estimate
CA$0.02
Revenue Estimate
15.085M
Revenue Q2Q
273.34%
EPS Q2Q
N/A
Number of Analysts
2

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

NURS.CA is expected to report earnings on 5/5/2026. The consensus EPS estimate for the next earnings is 0.02 CAD and the consensus revenue estimate is 15.09M CAD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
NURS.CA revenue by date.NURS.CA revenue by date.
4.27M
255.83%
11.51M
169.54%
16.045M
39.40%
36.148M
125.30%
151.37M
318.75%
196.02M
29.50%
EBITDA
YoY % growth
NURS.CA ebitda by date.NURS.CA ebitda by date.
-1.84M
-253.85%
-1.826M
0.78%
-260.1K
85.75%
2.075M
897.77%
23.052M
1,010.94%
35.42M
53.65%
EBIT
YoY % growth
NURS.CA ebit by date.NURS.CA ebit by date.
-1.88M
-261.54%
-1.934M
-2.87%
-441.2K
77.19%
1.588M
459.93%
22.724M
1,330.98%
38.162M
67.94%
Operating Margin
NURS.CA operating margin by date.NURS.CA operating margin by date.
-44.03%-16.80%-2.75%4.39%15.01%19.47%
EPS
YoY % growth
NURS.CA eps by date.NURS.CA eps by date.
N/AN/AN/A0.030.30
900.00%
0.49
63.33%

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.020.050.060.08
708.00%
0.11
450.00%
0.11
120.00%
0.12
100.00%
0.13
62.50%
0.14
27.27%
Revenue
Q2Q % growth
15.085M
273.34%
27.875M
513.97%
31.32M
326.18%
41.636M
295.78%
50.687M
236.01%
42.712M
53.23%
46.282M
47.77%
49.135M
18.01%
53.822M
6.19%
EBITDA
Q2Q % growth
1.184M
525.46%
3.923M
2,941.09%
4.493M
1,952.54%
6.542M
782.86%
8.294M
600.51%
8.411M
114.40%
9.273M
106.39%
9.945M
52.02%
11.093M
33.75%
EBIT
Q2Q % growth
1.23M
14,900.00%
3.794M
5,297.26%
4.362M
40,288.89%
6.409M
1,439.88%
8.159M
563.33%
8.274M
118.08%
9.133M
109.38%
9.804M
52.97%
10.949M
34.20%

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NURS.CA Yearly Revenue VS EstimatesNURS.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
NURS.CA Yearly EPS VS EstimatesNURS.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.1 0.2 0.3 0.4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
267.39%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
130.32%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
334.94%
EBIT Next 5 Year
N/A

HYDREIGHT TECHNOLOGIES INC / NURS.CA Forecast FAQ

What do analysts expect the price target to be for HYDREIGHT TECHNOLOGIES INC (NURS.CA)?

6 analysts have analysed NURS.CA and the average price target is 9.95 CAD. This implies a price increase of 169.51% is expected in the next year compared to the current price of 3.69.

When does HYDREIGHT TECHNOLOGIES INC (NURS.CA) report earnings?

HYDREIGHT TECHNOLOGIES INC (NURS.CA) will report earnings on 2026-05-05.

What are the consensus estimates for NURS stock next earnings?

The consensus EPS estimate for the next earnings of HYDREIGHT TECHNOLOGIES INC (NURS.CA) is 0.02 CAD and the consensus revenue estimate is 15.09M CAD.

What is the expected long term growth rate for NURS stock?

The expected long term growth rate for HYDREIGHT TECHNOLOGIES INC (NURS.CA) is 130.32%.